Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1536588
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immunogenicity and Safety of the Diphtheria, Pertussis, Tetanus and Inactivated Poliovirus Vaccine When Co-Administered With the Human Rotavirus Vaccine (Rotarix) in Healthy Japanese Infants: A Phase IV Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Safety and Immunogenicity of the DTP/HB /Hib Combination Vaccine: Phase I Study

Paediatrica Indonesiana
2013English

A Second Dose of a Measles-Mumps-Rubella Vaccine Administered to Healthy Four-To-Six-Year-Old Children: A Phase III, Observer-Blind, Randomized, Safety and Immunogenicity Study Comparing GSK MMR and MMR II With and Without DTaP-IPV and Varicella Vaccines Co-Administration

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana

PLoS ONE
Multidisciplinary
2008English

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2020English

Immunogenicity of a Combined DTPa-HB Vaccine Co-Administered With Haemophilus Influenzae Type B Conjugate Vaccine (PRP-T) for Primary and Booster Vaccinations

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2005English

Correction To: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon®): An Updated Review of Its Use in Primary and Booster Vaccination

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2019English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy